Albireo Pharma Incの発行済株式数
Albireo Pharma Incの発行済株式数は何ですか。
Albireo Pharma Incの発行済株式数は20.701Mです。
発行済株式数の定義は何ですか。
発行済株式数は、投資家によって承認、発行、購入され、保有されている法人または金融資産のすべての株式である。
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
NASDAQのセクタHealth Careにおける発行済株式数の企業と比べるAlbireo Pharma Inc
Albireo Pharma Incは何をしますか。
Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. Albireo's lead product candidate, odevixibat, is being developed to treat rare pediatric cholestatic liver diseases with Phase 3 pivotal trials in PFIC, Alagille syndrome and biliary atresia. The Company completed IND-enabling studies for new preclinical candidate A3907 this year and plans to advance development in adult liver disease. Albireo was spun out from AstraZeneca in 2008 and is headquartered in Boston, Massachusetts, with its key operating subsidiary in Gothenburg, Sweden. The Boston Business Journal named Albireo one of the 2020 Best Places to Work in Massachusetts for the second consecutive year.
Albireo Pharma Incと類似の発行済株式数
- Hemisphere Media Incの発行済株式数は20.680Mです。
- Backstageplayの発行済株式数は20.688Mです。
- Integrated Media Technologyの発行済株式数は20.688Mです。
- ad pepper media International NVの発行済株式数は20.691Mです。
- Seanergy Maritime Corpの発行済株式数は20.699Mです。
- CHSの発行済株式数は20.700Mです。
- Albireo Pharma Incの発行済株式数は20.701Mです。
- Intercontinental Gold and Metalsの発行済株式数は20.709Mです。
- Lefteris Acquisitionの発行済株式数は20.710Mです。
- Mineral Hill Industriesの発行済株式数は20.725Mです。
- Monte Carlo Fashionsの発行済株式数は20.732Mです。
- VPC Impact Acquisitionの発行済株式数は20.737Mです。
- Sphere 3D Corpの発行済株式数は20.743Mです。